• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6/信号转导与转录激活因子3信号通路的多态性可能与皮肤T细胞淋巴瘤易感性有关。

The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility.

作者信息

Olszewska Berenika, Gleń Jolanta, Zabłotna Monika, Nowicki Roman J, Sokołowska-Wojdyło Małgorzata

机构信息

Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, Mariana Smoluchowskiego Str 17, 80-214, Gdańsk, Poland.

出版信息

Arch Dermatol Res. 2021 Jan;313(1):25-31. doi: 10.1007/s00403-020-02062-5. Epub 2020 Apr 8.

DOI:10.1007/s00403-020-02062-5
PMID:32270320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7806529/
Abstract

IL-6/STAT3 signaling pathway has been suggested to play a role in CTCL pathogenesis. Polymorphisms in STAT3 signaling pathway-related genes might be a risk factor for CTCL. However, the exact role of inherited gene polymorphisms of IL-6 and STAT3 in the pathogenesis of CTCL is still not fully understood. The aim was to examine whether IL-6 cytokine and polymorphisms of IL-6 and STAT3 gene are associated with CTCL susceptibility, stage of disease and pruritus intensity. We compared the IL-6 serum level and the frequency of selected single nucleotide polymorphisms of IL-6 and STAT3 in 106 CTCL and 198 control group using polymerase chain reaction with sequence-specific primers method and ELISA. We have found that serum IL-6 level in CTCL patients was significantly higher than in healthy controls (p < 0.05). We also demonstrated that two genotypes, CC of IL-6 and GG of STAT3, were overexpressed in CTCL patients compared to healthy controls, and that they increase the risk of malignancy development (OR = 1.8, p = 0.04 for IL-6 and OR 2.53, p = 0.0064 for STAT3). Moreover, the GG genotype of STAT3 polymorphism seems to be associated with lack of pruritus or mild pruritus in CTCL patients. Our results indicate that IL-6 is involved in pathogenesis of CTCL but not pruritus. Moreover, CC of IL-6 and GG genotype of STAT3 genes might be considered as the risk factor for development of CTCL.

摘要

白细胞介素-6/信号转导与转录激活因子3(IL-6/STAT3)信号通路被认为在蕈样肉芽肿(CTCL)的发病机制中发挥作用。STAT3信号通路相关基因的多态性可能是CTCL的一个危险因素。然而,IL-6和STAT3的遗传基因多态性在CTCL发病机制中的确切作用仍未完全明确。本研究旨在探讨IL-6细胞因子以及IL-6和STAT3基因多态性是否与CTCL易感性、疾病分期及瘙痒强度相关。我们采用序列特异性引物聚合酶链反应法和酶联免疫吸附测定法,比较了106例CTCL患者和198例对照组中IL-6血清水平以及IL-6和STAT3特定单核苷酸多态性的频率。我们发现,CTCL患者的血清IL-6水平显著高于健康对照组(p < 0.05)。我们还证实,与健康对照组相比,CTCL患者中IL-6的CC基因型和STAT3的GG基因型过表达,且它们增加了恶性肿瘤发生的风险(IL-6的比值比(OR)= 1.8,p = 0.04;STAT3的OR = 2.53,p = 0.0064)。此外,STAT3基因多态性的GG基因型似乎与CTCL患者无瘙痒或轻度瘙痒有关。我们的结果表明,IL-6参与了CTCL的发病机制,但与瘙痒无关。此外,IL-6的CC基因型和STAT3基因的GG基因型可能被视为CTCL发生的危险因素。

相似文献

1
The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility.白细胞介素-6/信号转导与转录激活因子3信号通路的多态性可能与皮肤T细胞淋巴瘤易感性有关。
Arch Dermatol Res. 2021 Jan;313(1):25-31. doi: 10.1007/s00403-020-02062-5. Epub 2020 Apr 8.
2
STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.STAT3 多态性和 IL-6 多态性与波兰北部患者基底细胞癌的风险相关。
Arch Dermatol Res. 2019 Nov;311(9):697-704. doi: 10.1007/s00403-019-01952-7. Epub 2019 Jul 24.
3
IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.IL-22,而非 IL-17,在皮肤 T 细胞淋巴瘤中占主导地位。
Clin Cancer Res. 2011 Dec 15;17(24):7529-38. doi: 10.1158/1078-0432.CCR-11-1192. Epub 2011 Nov 2.
4
Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease.白细胞介素-31与早期皮肤T细胞淋巴瘤相关的瘙痒无关,但参与该疾病的发病机制。
Acta Derm Venereol. 2015 Mar;95(3):283-8. doi: 10.2340/00015555-1958.
5
Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma.神经生长因子、趋化因子(C-C 基序)配体和免疫球蛋白 E 与皮肤 T 细胞淋巴瘤瘙痒的关系。
Acta Derm Venereol. 2013 Mar 27;93(2):144-9. doi: 10.2340/00015555-1428.
6
Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas.描述原发性皮肤 T 细胞淋巴瘤中与瘙痒相关的细胞和介质。
Clin Exp Med. 2024 Jul 28;24(1):171. doi: 10.1007/s10238-024-01407-y.
7
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.在不同治疗方式下,蕈样肉芽肿(CTCL)患者瘙痒症状的改善与白细胞介素-31水平降低相关。
Clin Immunol. 2015 May;158(1):1-7. doi: 10.1016/j.clim.2015.02.014. Epub 2015 Mar 8.
8
Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.抑癌 microRNA-124 的表观遗传沉默直接支持皮肤 T 细胞淋巴瘤中 STAT3 的激活。
Cells. 2020 Dec 15;9(12):2692. doi: 10.3390/cells9122692.
9
Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3.皮肤T细胞淋巴瘤细胞系中白细胞介素-5的自发产生由持续激活的Stat3介导。
Blood. 2002 Feb 1;99(3):973-7. doi: 10.1182/blood.v99.3.973.
10
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.CCL20与CCR6相互作用的破坏可抑制晚期皮肤T细胞淋巴瘤的转移。
Oncotarget. 2016 Mar 22;7(12):13563-74. doi: 10.18632/oncotarget.6916.

引用本文的文献

1
Non-coding RNAs in the spotlight of the pathogenesis, diagnosis, and therapy of cutaneous T cell lymphoma.非编码RNA在皮肤T细胞淋巴瘤发病机制、诊断及治疗中的研究热点
Cell Death Discov. 2024 Sep 10;10(1):400. doi: 10.1038/s41420-024-02165-2.
2
H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma.H-1细小病毒在皮肤T细胞淋巴瘤新型异型球体模型中诱导的肿瘤溶解和肿瘤微环境免疫调节
Cancers (Basel). 2024 Jul 30;16(15):2711. doi: 10.3390/cancers16152711.
3
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets.

本文引用的文献

1
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.抗生素可抑制皮肤 T 细胞淋巴瘤的肿瘤和疾病活动。
Blood. 2019 Sep 26;134(13):1072-1083. doi: 10.1182/blood.2018888107. Epub 2019 Jul 22.
2
Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.晚期蕈样肉芽肿:信号转导和转录激活因子3、核因子κB及活化T细胞核因子通路的作用
Br J Dermatol. 2020 Jan;182(1):147-155. doi: 10.1111/bjd.18098. Epub 2019 Jul 25.
3
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.
细胞因子在皮肤 T 细胞淋巴瘤中的作用:聚焦最新进展和可能的治疗靶点。
Cells. 2024 Mar 28;13(7):584. doi: 10.3390/cells13070584.
4
Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes.遗传易感性与早期蕈样肉芽肿:研究组织驻留记忆 T 细胞基因中的遗传多态性。
J Int Med Res. 2024 Mar;52(3):3000605241239034. doi: 10.1177/03000605241239034.
5
Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.人源化 IL-15 小鼠中 Sezary 细胞依赖微环境的生长。
Dis Model Mech. 2023 Oct 1;16(10). doi: 10.1242/dmm.050190. Epub 2023 Oct 13.
6
Interleukin-17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility.白细胞介素-17 基因多态性与皮肤 T 细胞淋巴瘤易感性显著相关。
Acta Derm Venereol. 2022 Sep 21;102:adv00777. doi: 10.2340/actadv.v102.2416.
7
MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma.微 RNA 调控皮肤 T 细胞淋巴瘤中 T 细胞耗竭。
J Invest Dermatol. 2022 Mar;142(3 Pt A):603-612.e7. doi: 10.1016/j.jid.2021.08.447. Epub 2021 Nov 11.
8
Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma.表观遗传学在皮肤T细胞淋巴瘤发病机制及治疗中的作用
Front Oncol. 2021 Jun 24;11:663961. doi: 10.3389/fonc.2021.663961. eCollection 2021.
9
Targeted Approaches to T-Cell Lymphoma.T细胞淋巴瘤的靶向治疗方法
J Pers Med. 2021 May 27;11(6):481. doi: 10.3390/jpm11060481.
10
Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells.葫芦素E和I靶向JAK/STAT信号通路并诱导蕈样霉菌病细胞凋亡。
Biochem Biophys Rep. 2020 Oct 15;24:100832. doi: 10.1016/j.bbrep.2020.100832. eCollection 2020 Dec.
STAT3 rs4796793 与肺癌风险及铂类化疗的临床结局相关。
Int J Clin Oncol. 2019 May;24(5):476-484. doi: 10.1007/s10147-018-01386-7. Epub 2019 Jan 28.
4
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.2018 年版 WHO-EORTC 原发性皮肤淋巴瘤分类。
Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11.
5
Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.基因组分析显示蕈样肉芽肿中 JAK-STAT 信号通路抑制剂 HNRNPK 和 SOCS1 经常缺失。
Genes Chromosomes Cancer. 2018 Dec;57(12):653-664. doi: 10.1002/gcc.22679. Epub 2018 Oct 25.
6
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).对220例皮肤T细胞淋巴瘤(CTCL)进行的基因组分析确定了RLTPR(p.Q575E)中一种新的复发性功能获得性改变。
Blood. 2017 Sep 21;130(12):1430-1440. doi: 10.1182/blood-2017-02-768234. Epub 2017 Jul 10.
7
Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.皮肤T细胞淋巴瘤(CTCL)中的基因表达分析突出了疾病的异质性以及潜在的诊断和预后指标。
Oncoimmunology. 2017 Mar 17;6(5):e1306618. doi: 10.1080/2162402X.2017.1306618. eCollection 2017.
8
The role of polymorphism of , -, and α genes in cutaneous T-cell lymphoma pathogenesis., -, 和α基因多态性在皮肤T细胞淋巴瘤发病机制中的作用。
Postepy Dermatol Alergol. 2016 Dec;33(6):429-434. doi: 10.5114/ada.2016.63881. Epub 2016 Dec 2.
9
Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.涉及 Sézary 综合征中基因组维持和 DNA 修复的候选驱动基因。
Blood. 2016 Jun 30;127(26):3387-97. doi: 10.1182/blood-2016-02-699843. Epub 2016 Apr 27.
10
Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.皮肤 T 细胞淋巴瘤:2016 年诊断、风险分层和治疗更新。
Am J Hematol. 2016 Jan;91(1):151-65. doi: 10.1002/ajh.24233. Epub 2015 Nov 26.